These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8192105)

  • 41. FEC (5-fluorouracil, epidoxorubicin and cyclophosphamide) versus EM (epidoxorubicin and mitomycin-C) with or without lonidamine as first-line treatment for advanced breast cancer. A multicentric randomised study. Final results.
    Pacini P; Rinaldini M; Algeri R; Guarneri A; Tucci E; Barsanti G; Neri B; Bastiani P; Marzano S; Fallai C
    Eur J Cancer; 2000 May; 36(8):966-75. PubMed ID: 10885599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer.
    Wallerstein R; Spitzer G; Dunphy F; Huan S; Hortobagyi G; Yau J; Buzdar A; Holmes F; Theriault R; Ewer M
    J Clin Oncol; 1990 Nov; 8(11):1782-8. PubMed ID: 2121909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer.
    Powles TJ; Jones AL; Judson IR; Hardy JR; Ashley SE
    Br J Cancer; 1991 Aug; 64(2):406-10. PubMed ID: 1892775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mitomycin C and vinblastine: an active regimen in previously treated breast cancer patients.
    Ospovat I; Siegelmann-Danieli N; Grenader T; Hubert A; Hamburger T; Peretz T
    Tumori; 2009; 95(6):683-6. PubMed ID: 20210229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients.
    Mammoliti S; Merlini L; Caroti C; Gallo L
    Breast Cancer Res Treat; 1996; 37(1):93-6. PubMed ID: 8750532
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mitoxantrone, fluorouracil plus L-leucovorin, and vinorelbine in pretreated advanced breast cancer.
    Colleoni M; Nelli P; Gaion F; Sgarbossa G; Manente P
    Oncology; 1995; 52(6):435-8. PubMed ID: 7478426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer.
    Klaassen U; Harstrick A; Wilke H; Seeber S
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):44-7. PubMed ID: 8629037
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes.
    Tanabe M; Ito Y; Tokudome N; Sugihara T; Miura H; Takahashi S; Seto Y; Iwase T; Hatake K
    Breast Cancer; 2009; 16(4):301-6. PubMed ID: 19205831
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of mitoxantrone, 5-fluorouracil and high-dose leucovorin in the treatment of advanced breast cancer.
    Hainsworth JD
    Ann Oncol; 1993; 4 Suppl 2():37-40. PubMed ID: 7688982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase II study of weekly mitoxantrone, 5-fluorouracil, and leucovorin in metastatic breast cancer.
    Repetto L; Miglietta L; Gardin G; Lanfranco C; Naso C; Merlini L; Giudici S; Venturino A; Campora E; Testore F
    Breast Cancer Res Treat; 1994; 30(2):133-7. PubMed ID: 7949211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mitoxantrone (M) and vinblastine (V) in the treatment of advanced breast cancer.
    Cruciani G; Tienghi A; Fiorentini G; Rosti G; Turci D; Salerno V; Leoni M; Marangolo M
    Tumori; 1990 Apr; 76(2):196-8. PubMed ID: 2184548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer.
    Samonigg H; Stöger H; Kasparek AK; Schmid M; Dusleag J; Pfeiffer K; Smola M; Steindorfer P; Lechner P
    Cancer Chemother Pharmacol; 1991; 27(6):477-80. PubMed ID: 2013118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients.
    Ozdemir N; Aksoy S; Sendur MA; Akinci MB; Yazici O; Budakoglu B; Abali H; Oksuzoglu B; Zengin N
    J BUON; 2013; 18(4):831-7. PubMed ID: 24344005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase I trial of high-dose mitoxantrone plus cyclophosphamide and filgrastim in patients with advanced breast carcinoma.
    Sparano JA; Robert N; Silverman P; Lazarus H; Malik U; Venkatraj U; Sarta C
    J Clin Oncol; 1996 Sep; 14(9):2576-83. PubMed ID: 8823338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Doxorubicin versus mitomycin versus doxorubicin plus mitomycin in advanced breast cancer: a randomized study.
    Andersson M; Daugaard S; von der Maase H; Mouridsen HT
    Cancer Treat Rep; 1986 Oct; 70(10):1181-6. PubMed ID: 3530444
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer.
    Gennari A; Guarneri V; Landucci E; Orlandini C; Rondini M; Salvadori B; Ricci S; Conte PF
    Clin Breast Cancer; 2002 Dec; 3(5):346-52. PubMed ID: 12533265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prophylactic filgrastim (G-CSF) during mitomycin-C, mitoxantrone, and methotrexate (MMM) treatment for metastatic breast cancer. A randomized study.
    Muhonen T; Jantunen I; Pertovaara H; Voutilainen L; Maiche A; Blomqvist C; Pyrhönen S; Kellokumpu-Lehtinen P
    Am J Clin Oncol; 1996 Jun; 19(3):232-4. PubMed ID: 8638531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Randomized phase II trial on mitomycin-C/cisplatin +/- KLT in heavily pretreated advanced breast cancer.
    Guo HY; Cai Y; Yang XM; Wang ZH; Wang JL; Zhao XM; Li J; Hu XC
    Am J Chin Med; 2008; 36(4):665-74. PubMed ID: 18711764
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination chemotherapy with epirubicin and mitomycin C as first-line treatment in advanced breast cancer.
    Pacini P; Tucci E; Algeri R; Rinaldini M; Guarnieri A; Valzelli S; Neri B
    Eur J Cancer; 1994; 30A(4):460-3. PubMed ID: 7517150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase II study of irinotecan and mitomycin C in 5-fluorouracil-pretreated patients with advanced colorectal and gastric cancer.
    Bamias A; Papamichael D; Syrigos K; Pavlidis N
    J Chemother; 2003 Jun; 15(3):275-81. PubMed ID: 12868555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.